3nga: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "3nga" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3nga.png|left|200px]] | [[Image:3nga.png|left|200px]] | ||
{{STRUCTURE_3nga| PDB=3nga | SCENE= }} | {{STRUCTURE_3nga| PDB=3nga | SCENE= }} | ||
===Human CK2 catalytic domain in complex with CX-4945=== | ===Human CK2 catalytic domain in complex with CX-4945=== | ||
{{ABSTRACT_PUBMED_21093442}} | {{ABSTRACT_PUBMED_21093442}} | ||
==About this Structure== | ==About this Structure== | ||
[[3nga]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3NGA OCA]. | [[3nga]] is a 2 chain structure of [[Casein kinase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3NGA OCA]. | ||
==See Also== | |||
*[[Casein kinase|Casein kinase]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:021093442</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Non-specific serine/threonine protein kinase]] | [[Category: Non-specific serine/threonine protein kinase]] | ||
[[Category: Ferguson, A D.]] | [[Category: Ferguson, A D.]] | ||
[[Category: Ck2]] | |||
[[Category: Inhibitor]] | |||
[[Category: Kinase]] | |||
[[Category: Transferase-transferase inhibitor complex]] | |||
Revision as of 18:18, 26 July 2012
Human CK2 catalytic domain in complex with CX-4945
Template:ABSTRACT PUBMED 21093442
About this Structure
3nga is a 2 chain structure of Casein kinase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Ferguson AD, Sheth PR, Basso AD, Paliwal S, Gray K, Fischmann TO, Le HV. Structural basis of CX-4945 binding to human protein kinase CK2. FEBS Lett. 2010 Nov 18. PMID:21093442 doi:10.1016/j.febslet.2010.11.019